IL13 and systemic sclerosis: SSc may be categorised, at least partially, as a Th2-dependent disease, with a prominent Th2 immune response and the subsequent release of Th2-dependent cytokines, such as IL-4, IL-5, and IL-13, which are able to control the fibrotic process [73].